Table 3.

Time schedule

	TRIAL PERIOD						FOLLOW-UP
	Screening visit	Pre-study	During study				Year 1	Year 2	Year 3 till ∞
			Every SABR fraction	Last day of SABR	3 months after SABR	6 months after SABR	Every 3 months	Every 6 months	yearly
Informed consent	x
Clinical examination	x			x	x	x	x	x	x
Registration of toxicity		x		x	x	x	x	x	x
Registration of QoL		x		x	x	x	x	x	x
Blood sample		x	x	x	x	x
Imaging						x